Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

EU Tissue Laws: TSE Directive Issued, Industry Awaits Additional HTP Rules

This article was originally published in The Gray Sheet

  • News

Executive Summary

European Union member states must adopt and publish the European Commission's new directive on medical devices using tissues of animal origin by Jan. 1, 2004

You may also be interested in...



TSE CE Mark Process Simplified By EDQM Certification Of Suitability

Manufacturers that have devices on the European market utilizing tissue derived from certain animals must have a TSE CE mark certificate starting May 1

TSE CE Mark Process Simplified By EDQM Certification Of Suitability

Manufacturers that have devices on the European market utilizing tissue derived from certain animals must have a TSE CE mark certificate starting May 1

EU Tissue Procurement Directive Adopted; HTP Draft Forthcoming

The European human tissue product (HTP) market likely will be more navigable - and increasingly attractive to large firms - following the adoption of a pending EU tissue product directive

Table

View full table

Related Content

Medtech Insight
Medtech Insight
Tags:
Latest Headlines

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win

See All
UsernamePublicRestriction

Register

MT018358

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By